Macrogenics (MGNX) Free Cash Flow (2012 - 2026)

Macrogenics' (MGNX) quarterly Free Cash Flow came in at -$36.1 million in Q1 2026, up 23.61% year-on-year from -$29.2 million in Q1 2025, and down 183.97% on a QoQ basis from $43.0 million in Q4 2025.

Macrogenics (MGNX) Free Cash Flow (2012 - 2026) Analysis & Trends

Macrogenics (MGNX) has 15 years of Free Cash Flow data on file, last reported at -$36.1 million in Q1 2026.

  • On a quarterly basis, Free Cash Flow rose 23.61% year-over-year to -$36.1 million in Q1 2026; TTM through Mar 2026 was -$69.9 million, a 4.76% increase from a year earlier, with the FY2025 full-year figure at -$81.1 million, down 12.51% from the prior year.
  • Free Cash Flow for Q1 2026 stood at -$36.1 million, down from $43.0 million in the prior quarter.
  • Over the last five years, Free Cash Flow for MGNX reached as high as $57.1 million in Q3 2024 and fell as low as -$59.1 million in Q1 2022.
  • Historically, Free Cash Flow has averaged -$21.1 million across 5 years, with a median of -$35.7 million in 2023.
  • On a YoY basis, Free Cash Flow climbed as much as 259.78% in 2024 and fell as far as 1631.68% in 2024.
  • Year by year, Free Cash Flow stood at $28.9 million in 2022, then slumped by 194.71% to -$27.4 million in 2023, then sank by 42.44% to -$39.0 million in 2024, then surged by 210.11% to $43.0 million in 2025, then slumped by 183.97% to -$36.1 million in 2026.
  • Per Business Quant data, the three most recent Free Cash Flow figures were -$36.1 million in Q1 2026, $43.0 million in Q4 2025, and -$30.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -19.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 158.09 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.53 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.29 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 848.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -354.95 Mn
10 Macrogenics 254.43 Mn 187.92 Mn - -36.09 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -36.09 Mn
Mar 31, 2026 -36.09 Mn
Dec 31, 2025 42.97 Mn
Dec 31, 2025 42.97 Mn
Sep 30, 2025 -30.16 Mn
Sep 30, 2025 -30.16 Mn
Jun 30, 2025 -46.67 Mn
Jun 30, 2025 -46.67 Mn
Mar 31, 2025 -47.24 Mn
Mar 31, 2025 -47.24 Mn
Dec 31, 2024 -39.03 Mn
Dec 31, 2024 -39.03 Mn
Sep 30, 2024 57.11 Mn
Sep 30, 2024 57.11 Mn
Jun 30, 2024 -44.28 Mn
Jun 30, 2024 -44.28 Mn
Mar 31, 2024 -45.89 Mn
Mar 31, 2024 -45.89 Mn
Dec 31, 2023 -27.40 Mn
Dec 31, 2023 -27.40 Mn